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INTRODUCTION 
Seizures are devastating events in a person’s life. Their very 
presence suggests that something is wrong with the Brain. 
Seizures are relatively common neurological complication in 
patients admitted in intensive medical care unit. They commonly arise 
from comorbidities associated with the ICU experience. Most ICU 
seizures occur in patients who have not had a prior episode or for whom 
neurological pathology was part of the primary admitting diagnosis. 
The ICU environment unfortunately presents unique challenges 
and difficulties with regard to the etiology, diagnosis and management of 
seizures, because in ICU, patients are  critically ill, frequently with 
multiple organ dysfunction , treated with medications that may lower 
seizure threshold, and prevent good neurological estimation. 
Since the incidence of seizures occurs most often in non-primary 
neurological patients, it is  important  for  the  general  clinician,  
intensivist,  and consulting neurologist to know about the potential for 
seizures in the ICU and to be aggressive in treating them. 
Multiple seizure events or convulsive status epilepticus may lead to 
acidosis,hyperthermia,rhabdomyolysis,and trauma, and consequent high 
morbidity and mortality. Hence the need to diagnose and effectively treat 
seizure activity is imperative. 
An effort has been made by this study to unravel the various 
aspects of seizures in IMCU in our hospital 
REVIEW OF LITERATURE 
Seizure (from the Latin Sacire, “to take possession of” is a 
paroxysmal event that occurs  due to abnormal, excessive, hyper 
synchronous discharges from an aggregate of central nervous system 
(CNS) neurons
1, 2
.  
Historical Background 
Seizures have been recognized since antiquity. One of the earliest 
descriptions
3
 of a secondarily generalized tonic-clonic seizure was 
recorded over 3000 years ago in Mesopotamia, which was attributed to 
the God of the Moon. Epileptic seizures were described in ancient 
cultures including those of China, Egypt, and India. 
Basic concepts surrounding seizures and epilepsy are found in 
Ancient Indian medicine which dates back to Vedic period of 4500-
1500BC.In the Ayurvedic literature of Charaka Samhita, seizures were 
identified and epilepsy was described as "apasmara" which means "loss 
of consciousness".
4
 
The foundation of our modern understanding of the derangement of 
function seen in seizures and epilepsy was laid in the 19th century with 
the work of Hughlings Jackson. Working in Germany during the 1920s, 
Hans Berger, a psychiatrist, developed the human electroencephalograph. 
Another recent stimulus towards the understanding and treatment of 
seizures in the last few decades has been the development in 
neuroimaging. Recent technology has revealed many of the more subtle 
brain lesions producing seizures. 
Definitions of Terms 
[As per the International League against Epilepsy (ILAE) Guidelines 
(Jallon, 1993; Roger, 1989).] 
5 
A nonepileptic event is a clinical event presumed to be unrelated 
to
 
abnormal and excessive neuronal discharge. An example of a 
nonepileptic
 
event is syncope.
 
An epileptic seizure is a clinical event presumed to result from an 
abnormal
 
and excessive neuronal discharge. The clinical symptoms are 
paroxysmal
 
and may include impaired consciousness and motor, sensory, 
autonomic, or
 
psychic events perceived by the subject or an observer.
 
 
A provoked seizure is an acute symptomatic seizure that occurs 
following a
 
recent acute disorder such as a metabolic insult, toxic insult, 
CNS infection,
 
stroke, brain trauma, cerebral hemorrhage, medication 
toxicity, alcohol
 
withdrawal, or drug withdrawal.
 
An unprovoked seizure is a cryptogenic or a remote symptomatic 
seizure.
 
Epilepsy occurs when 2 or more epileptic seizures occur 
unprovoked by any
 
immediately identifiable cause. The seizures must 
occur more than 24 hours
 
apart. In epidemiologic studies, an episode of 
status epilepticus is considered as a single seizure. Febrile seizures and 
neonatal seizures are excluded from
 
this category.
 
Classification of Seizures 
Seizures are divided into two broad categories--generalized and 
partial . Generalized seizures arise from both sides of the brain 
simultaneously. Partial (ie, focal) seizures occur within one or more 
restricted regions of the brain and are a secondary effect of a localized 
physiologic or structural abnormality of the brain (eg, tumor, dysplasia, 
stroke, trauma). 
International League Against Epilepsy Revised Classification of 
Epileptic Seizures
1 
Classification of Seizures 
1. Partial seizures  
 Simple partial seizures (with motor, sensory, autonomic, or psychic 
signs)  
 Complex partial seizures  
 Partial seizures with secondary generalization 
2. Primarily generalized seizures  
 Absence (petit mal)  
 Tonic-clonic (grand mal)  
 Tonic  
 Atonic  
 Myoclonic 
3. Unclassified seizures  
 Neonatal seizures  
 Infantile spasms 
Classification of status epilepticus: 
Status epilepticus refers to continuous seizures or repetitive, 
discrete seizures with impaired consciousness in the interictal period. A 
more practical definition is to consider status epilepticus as a situation in 
which the duration of seizures prompts the acute use of anticonvulsant 
therapy. For GCSE, this is typically when seizures last beyond 5 min. 
Status epilepticus has numerous subtypes 
1. Generalized convulsive status epilepticus (GCSE) (e.g., persistent, 
generalized electrographic seizures, coma, and tonic-clonic 
movements),  
2. Nonconvulsive status epilepticus (e.g., persistent absence seizures or 
partial seizures, confusion or partially impaired consciousness, and 
minimal motor abnormalities) 
Epidemiology: 
In contemporary society, the frequency and importance of epilepsy 
can hardly be overstated. The prevalence of epilepsy is 4-8 per cent
6
. The 
causes of epilepsy differ in different parts of the world. Infections as a 
cause of epilepsy are more common in developing countries. Solitary 
lesions of neuro cysticercosis are an important cause of epilepsy in India.  
From the epidemiologic studies of Hauser and colleagues, one may 
extrapolate an incidence of approximately 2 million individuals in the 
United States who are subject to epilepsy (i.e., chronically recurrent 
cerebral cortical seizures) and predict about 44 new cases per 100,000 
population occur each year.  
Over two-thirds of all epileptic seizures begin in childhood (most 
in the first year of life), and this is the age period when seizures assume 
the widest array of forms. The incidence increases again slightly after age 
60. It is, however, notable that in striking contrast to the many treatments 
available for epilepsy, as pointed out by J. Engle, 80 to 90 percent of 
epileptics in the developing world never receive treatment. 
A review by Bleck et al.noted that approximately 12% of patients 
admitted with a nonneurological primary diagnosis incurred  neurological 
events during their critical illness. Of these incidence of  seizures(28.1%) 
closely followed  the metabolic encephalopathy as a leading neurological 
complication 
Etiology of seizures in IMCU
7
:     
1. Anoxic encephalopathy 
2. CNS infections 
• Brain abscess 
• Encephalitis 
• Meningitis 
• Subdural empyema 
3. Cerebrovascular disorders 
 CNS vasculitis 
 Ischaemic stroke  
 Cortical vein thrombosis 
 Hemorrhage (ICH and SAH) 
 Lupus cerebritis 
 Thrombotic Thrombocytopenic Purpura  
4. Drug intoxication
8
 
 Antibiotics with proconvulsant effects 
 High dose penicillin in patients with renal failure 
 Imipenem – cilastin in patients with renal failure or damaged BBB 
 Cocaine and other central stimulants  
 Dopamine antagonists 
 Meperidine metabolites 
 Theophyllin 
 Tramadol 
 Tri cyclic anti depressants    
5. Drug / substance withdrawal  
 Alcohol 
 Benzodiazepines 
 Barbiturates 
 Opiates 
 Withdrawal of other anticonvulsants in patients with h/o seizure or 
a seizure disorder 
6. Head trauma  
 Contusion  
 Hemorrhage 
7. Metabolic encephalopathy- acute severe hypo osmolality (water 
intoxication) 
8. Hepatic failure 
9. Acute renal failure 
10. Chronic renal failure  
 Drugs or metabolite intoxication  
 Dialysis dementia 
11. Tumor 
 Primary  
 Metastatic 
12. Hypertensive encephalopathy 
13. Inflammatory diseases 
 Vasculitis 
 Acute disseminated encephalomyelitis 
  
Pathophysiology of ICU Seizures
9
 : 
The manifestations of ictal process emanate from a few common 
cellular mechanisms and brain foci. The cerebral cortex is the nidus for 
most clinically evident seizures, and into that category also falls the 
hippocampus, the most rudimentary cortical element of the medial 
temporal lobe and thalamus.  
As evidenced by the cortical EEG, the fundamental marker for an 
epileptic paroxysm is the interictal spike, which is the electrical finger 
print of the intracellular paroxysmal depolarizing shift ( PDS) The 
interictal spike is generated by a synchronous firing of a network of local 
neurons, coupled with periods of inhibition via K+ current activated 
hyperpolarisation. Neurons in particular that are readily disposed to such 
activity are the pyramidal cells of cortical layer V and the CA 3 neurons 
in the hippocampus. The paroxysmal discharge may be induced by a local 
increase in excitation, decrease inhibitory neurotransmission, or alteration 
in Na 
+
 or K
+
 current conductance. On a regional scale, ictal events may 
spread by disruption of the local chemical environment, such as 
alterations in K
+
 or Mg2+. Such spread is not very rapid and it is  
estimated to be at 50 – 200 mm/sec. Clinically important seizure 
propagation must clearly utilize synaptic transmission via networked 
connections.  
 
Clinical Manifestations: 
Determining the type of seizure that has occurred is essential for 
focusing the diagnostic approach on particular etiologies, selecting the 
appropriate therapy, and for providing vital information regarding 
prognosis. In 1981, the International League against Epilepsy (ILAE) 
published a modified version of the International Classification of 
Epileptic Seizures which has continued to be a useful classification 
system. This system is based on the clinical features of seizures and 
associated electroencephalographic findings. 
A fundamental principle is that seizures may be either partial 
(synonymous with focal) or generalized. Partial seizures are those in 
which the seizure activity is restricted to discrete areas of the cerebral 
cortex. Generalized seizures involve diffuse regions of the brain 
simultaneously. Partial seizures are usually associated with structural 
abnormalities of the brain. In contrast, generalized seizures may result 
from cellular, biochemical, or structural abnormalities that have a more 
widespread distribution. 
Three problems occur in recognizing the seizure in IMCU  
1. Complex partial seizures in patients with already impaired 
consciousness 
2. Seizures in patient receiving NMJ blockade 
3. Misinterpretation of movement disorders and psychogenic 
disturbances as seizures 
EEG is useful at this time in particular to diagnose non convulsive 
status epilepticus 
Diagnostic Approach
10
: 
The most important intervention done during a single seizure is 
careful observation. The first step in evaluating a suspected seizure is to 
determine whether the event was, in fact, a seizure . 
Convulsive syncope occurs when there is severe or prolonged 
reduction of blood flow to the brain, resulting in an event resembling 
tonic clonic seizure.  
Diagnosis is based on possible provocative factors in the medical 
history (eg, pain, dehydration), physical examination (eg, orthostatic 
blood pressure check), and studies such as electrocardiography and tilt 
table testing. 
Another common imitator of epileptic seizure is the nonepileptic 
psychogenic seizure. No single feature reliably differentiates the two 
disorders. However, many ictal features of nonepileptic psychogenic 
seizure are uncommon in epileptic seizures. For example, such features as 
gradual onset, stopping and restarting of motor activity, out-of-phase 
clonic movements of the extremities, vocalization in the middle of the 
seizure rather than at the start, pelvic thrusting, and lack of body rigidity 
are more common in psychogenic seizures than in tonic-clonic seizures. 
In addition, the typical duration of a tonic-clonic seizure is 50 to 92 
seconds, whereas the range for psychogenic seizures is 20 to 805 
seconds
11
. 
Furthermore, some epileptic seizures have symptoms that are 
frequently misdiagnosed as psychogenic. Frontal lobe complex partial 
seizures often last less than 1 minute and sometimes include rocking, 
kicking, "bicycling," pelvic thrusting, genital manipulation, and cursing. 
Their lack of postictal symptoms also makes frontal lobe seizures difficult 
to differentiate from psychogenic seizures. 
Other NonEpileptic Paroxysmal Events 
 Migraine (classic [with auras], basilar, confusional) 
 Cerebrovascular event (transient ischemic attack) 
 Periodic paralysis 
 Sleep disorders (parasomnias, daytime amnestic episodes) 
 Gastrointestinal disorders (reflux, motility disorders) 
 Movement disorders (tics, Tourette's syndrome, nonepileptic 
myoclonus, paroxysmal choreoathetosis, shuddering attacks) 
 Psychiatric disorders (panic, somatization, dissociation, conversion 
[nonepileptic psychogenic seizures]) 
 Drug toxicity and substance abuse 
 Breath-holding spells 
History of the event
10
  
A description of the circumstances during a paroxysmal event can 
provide important diagnostic clues. A witnessed, 90-second episode that 
involved loss of consciousness, stiffening, and jerking of the extremities 
followed by muscle soreness, headache, and the need to sleep for several 
hours afterwards strongly suggests a tonic-clonic seizure 
Key Elements in History 
Before the event 
 Unusual stress (eg, severe emotional trauma) 
 Sleep deprivation 
 Recent illness 
 Unusual stimuli (eg, flickering lights) 
 Use of medications and drugs 
 Activity immediately before event (eg, change in posture, exercise) 
During the event 
 Symptoms at onset (eg, aura) 
 Temporal mode of onset: gradual versus sudden 
 Duration: brief (ictal phase <5 min) versus prolonged 
 Stereotypy: duration and features of episodes nearly identical versus 
frequently changing 
 Time of day: related to sleep or occuring on awakening 
 Ability to talk and respond appropriately 
 Ability to comprehend 
 Ability to recall events during the seizure 
 Abnormal movements of the eyes, mouth, face, head, arms, and legs 
 Bowel or bladder incontinence 
 Bodily injury 
After the event 
 Confusion 
 Lethargy 
 Abnormal speech 
 Focal weakness or sensory loss (ie, Todd's paralysis) 
 Headache, muscle soreness, or physical injury 
Past medical history 
A review of the events leading up to the seizure may reveal factors 
that suggest that it was provoked. Causes of provoked seizures include 
alcohol withdrawal, substance abuse, hypoxia, fever, electrolyte 
imbalance, hypoglycemia, and sleep deprivation. 
Drug history 
Theophylline, meperidine hydrochloride , isoniazid , antipsychotic 
drugs (especially clozapine and phenothiazines), radiocontrast dyes, 
alkylating agents, and ß-lactam antibiotics are among the most commonly 
implicated medications in seizure. 
 
However, many other drugs can cause seizure, including lidocaine 
hydrochloride, general anesthetics, tricyclic antidepressants , selective 
serotonin reuptake inhibitors, bupropion hydrochloride, acyclovir,  
ßblockers, and decongestants (eg, phenylpropanolamine hydrochloride). 
Also, seizures can be provoked by alcohol withdrawal as well as use of 
cocaine. 
Physical examination 
A thorough physical examination can help to uncover possible 
causes of a seizure. Findings may include evidence of trauma, infection, 
malignancy, congenital anomalies, and prior neurologic events (eg, focal 
weakness, spasticity suggesting previous stroke). 
During an emergency department evaluation of a patient 
immediately after a seizure, vital signs should be measured and a general 
medical examination performed. Guidelines for physical examination are 
as follows: 
 Examine the patient for injuries from the seizure or a fall. 
 Check oxygen saturation and auscultate the chest for possible 
aspiration. 
 Measure heart rhythm and rate, blood pressure, and orthostatic 
changes for assessment of syncope. 
 Auscultate for carotid murmurs or carotid bruits and sources of 
embolic stroke. 
 Check for rapid pulses, which are often present after seizure and may 
help in evaluation of psychogenic seizures. 
An electrocardiogram should be obtained to identify cardiac 
rhythm, detect possible ischemia, and to measure the QT interval. 
Prolonged QT syndrome often presents with simple or convulsive 
syncope. Electrocardiography and 24-hour ambulatory continuous 
electrocardiographic (Holter) monitoring can help identify cardiac 
arrhythmias. The possibility of a recent myocardial infarction should be 
considered, particularly in elderly patients, in whom myocardial 
infarction may occur from the stress of a seizure. 
Neurologic examination 
 The purpose of the neurologic examination is to identify focal or 
diffuse cerebral dysfunction. This information is particularly helpful in 
localization related epilepsy. The presence of various features offers clues 
to the focus of a seizure. For example, aphasia suggests a left frontal, 
temporal, or parietal onset. Right or left hemiparesis suggests foci from 
the contralateral motor cortex. 
In initial evaluation of a seizure, patients should be observed for 
fluency of language, facial asymmetry, gaze preferences, and pupillary 
asymmetry. The last presents in patients  who have herniation from      
brain swelling     caused       by parenchymal or epidural bleeding and in 
those who have a rapidly growing brain tumor. The presence of pronator 
drift may indicate subtle weakness not detected by strength testing. 
Sensory deficits suggest parietal lobe dysfunction. An extensor plantar 
response may be noted for some time after a seizure and is not necessarily 
a pathologic finding. 
Diagnostic testing 
The investigations are aimed to obtain lab studies based upon age 
and etiology, basic investigations, toxicology screening and 
anticonvulsant levels (if indicated by H/o ingestion or existent therapy). 
Laboratory workup is an essential part of evaluation of seizure. 
Measurement of glucose, calcium, magnesium, thyroid hormone, and 
liver enzyme levels, as well as toxicology screening (including blood 
alcohol levels), may reveal common medical causes of seizures. A 
complete blood cell count may suggest infection, anemia, or sickle cell 
disease. In patients suspected to have had an infection or a fever or to 
have exhibited abnormal behavior just before the event, lumbar puncture 
should be performed after assessment of the possible risks of the 
procedure (eg, coagulopathy, mass lesion). Patients who are 
immunocompromised because of corticosteroid use, recent 
transplantation, or HIV infection should undergo cerebrospinal fluid 
evaluation to detect possible fungal, bacterial, or viral infection. In 
patients with a systemic malignant condition, cytologic evaluation of 
cerebrospinal fluid can identify meningeal carcinoma. 
Electroenchephologram: 
 EEG should be performed within 24 hours of the seizure because it is 
significantly more sensitive when obtained during that period 
(King,1998). If the routine EEG findings are normal, a sleep-deprived 
EEG  should be performed. 
 Standard EEG detects epileptiform discharges in 29% of patients. 
Standard EEG combined with sleep-deprived EEG shows epileptiform 
discharges in 48% of patients (van Donselaar, 1992)
12
. 
 In 2000, Simpson et al described a case in which the placement of an 
insertable loop recorder, an important new tool in the diagnostic 
evaluation of patients with syncope, led to an unexpected diagnosis of 
a seizure. Whenever cardiovascular causes are considered as the cause 
of a patient's spells but cannot be proven with conventional 
investigations, the use of the insertable loop recorder should be 
considered. 
 Schreiner and Pohlman-Eden studied the value of an EEG taken 
within 48 hours of the first seizure in an adult. They found that 38.0% 
of patients without seizure recurrence had normal EEGs, while only 
10.2% of patients with seizure recurrence had normal EEGs. Focal 
epileptiform activities were found significantly more 
frequently(26.5% vs. 13.0%) in patients with seizure recurrence than 
in patients without seizure recurrence. 
Limitation of EEG
13
: 
An estimated 0.4% of adults and 2.8% of children who have never 
had a seizure may have interictal  epileptiform discharges . Furthermore, 
a normal EEG does not refute the diagnosis of epilepsy. The initial  EEG 
reveals epileptiform activity in only 40% of the patients with probable 
epilepsy. 
Imaging studies 
The role of imaging studies depends on the stage of evaluation. 
Immediately after a seizure, computed tomography can detect the 
presence of bleeding or gross structural lesions. However, magnetic 
resonance imaging is the study of choice because it is more sensitive and 
specific for evaluating structural lesions of brain parenchyma. Particular 
attention should be directed to the hippocampus for evaluation of lesions 
(eg, mesial temporal sclerosis) and the cortical architecture for detection 
of abnormalities (eg, dysplasia). 
Principles of Seizure Management
1
: 
Therapy for a patient with a seizure disorder is almost always 
multimodal and includes treatment of underlying conditions that cause or 
contribute to the seizures, avoidance of precipitating factors, suppression 
of recurrent seizures by prophylactic therapy with antiepileptic 
medications or surgery, and addressing a  variety of psychological and 
social issues. 
Treatment of Underlying Conditions 
If the sole cause of a seizure is a metabolic disturbance such as an 
abnormality of serum electrolytes or glucose, then treatment is aimed at 
reversing the metabolic problem and preventing its recurrence. Therapy 
with antiepileptic drugs is usually unnecessary unless the metabolic 
disorder cannot be corrected promptly and the patient is at risk of having 
further seizures. If the apparent cause of a seizure was a medication (e.g., 
theophylline) or illicit drug use (e.g., cocaine), then appropriate therapy is 
avoidance of the drug; there is usually no need for antiepileptic 
medications unless subsequent seizures occur in the absence of these 
precipitants. 
Seizures caused by a structural CNS lesion such as a brain tumor, 
vascular malformation, or brain abscess may not recur after appropriate 
treatment of the underlying lesion. However, despite removal of the 
structural lesion, there is a risk that the seizure focus will remain in the 
surrounding tissue or develop de novo as a result of gliosis and other 
processes induced by surgery, radiation, or other therapies. Most patients 
are therefore maintained on an antiepileptic medication for at least 1 year, 
and an attempt is made to withdraw medications only if the patient has 
been completely seizure-free. If seizures are refractory to medication, the 
patient may benefit from surgical removal of the epileptic brain region. 
 
Avoidance and treatment of Predisposing Factors : 
In the intensive care unit setting, seizures are a common 
neurological complication in both medical and post surgical patients. 
They commonly arise from the comorbities associated with the ICU 
experience.  
Complications of Critical Illness Increasing Seizure Predisposition
7
: 
 Hypoxia / ischemia 
 Drug / substance toxicity  
• Antibiotics  
• Antidepressants 
• Antipsychotics 
• Bronchodilators 
• Local anesthetics 
• Immunosuppressives 
• Cocaine 
• Amphetamines 
• Phencyclidine 
 Drug / substance withdrawal 
• Barbiturates 
• Benzodiazepines 
• Opiods 
• Alcohol 
 Infection and fever  
 Metabolic abnormalities 
• Hypophosphatemia 
• Hypocalcemia 
• Hypoglycemia 
• Renal / hepatic dysfunction 
 Surgical injury ( craniotomy ) 
Hence avoidance or correction of the above factors is essential to 
prevent the recurrent episodes of seizures in the IMCU settings. 
Treatment 
Optimal treatment of seizures in  the ICU, involve both the acute 
cessation of ictal activity and preventing recurrence, ideally by removing 
or correcting the physiological trigger and providing  pharmacological 
prophylaxis against recurrence. Most commonly, seizures manifest as 
single episodes which serve to alert the care givers in dramatic fashion 
that a metabolic or structural abnormality exists, 
For immediate treatment of seizures, benzodiazepines are 
considered as the first line of therapy. They penetrate into brain rapidly, 
are potent GABA agonists, and serve to improve local inhibition of signal 
transmission. Commonly used benzodiazepines include diazepam, 
midazolam, or lorazepam. Each has a unique pharmacokinetic profile. 
Diazepam has been the popular standard, although its use against seizures 
is waning owing to the superior properties of the other two, highly 
lipophilic, diazepam rapidly redistributes away from the serum into fat. 
The result is that its effective anticonvulsant duration is on the order of 
only a few minutes, although its elimination time from the body is many 
hours and the longest of the three agents (23). Such kinetics could 
possibly result in brief seizure control yet a prolonged sedative effect if 
large dosages are required. 
Midazolam is also highly lipophilic and short acting, but is cleared 
by the liver much more rapidly than diazepam(> lOx) resulting in better 
correlation between drug effect and clearance (24). Lorazepam, a 
compound with greater water solubility that prolongs its serum half-life, 
is clinically effective for several hours (25). In a recent  randomized 
controlled trial with patients in status epilepticus, lorazepam was found to 
be superior than diazepam or phenytoin alone in terminating clinical and 
EEG seizures (25). Thus, it is reasonable to use lorazepam to the 
treatment of all GTCS in the ICU since rapid, maximal control is desired. 
In patients in whom prolonged sedation may seriously confound 
neurological management, initial treatment of seizures may be instituted 
with a short acting benzodiazepine to be followed immediately by a 
loading dose of phenytoin.  
Once seizures are controlled, monotherapy  with phenytoin for 
seizures is advocated to lessen the complications of drug interactions.    
Seizure recurrence should be managed first with acute treatment, again 
typically with benzodiazepines, followed by increasing serum  
concentrations of the primary anticonvulsant to high or maximal 
therapeutic levels. Should seizures become refractory, continuous EEG 
monitoring, intravenous  phenytoin or inhalational anesthetics are 
recommended. 
As alluded to earlier, it is important to realize that seizures 
occurring in the ICU setting may have unusual causes with complex 
features and treatments. Convulsions from theophylline toxicity carry a 
risk of morbidity and mortality that may exceed 40% (26) and part of the 
reason may be due to the fact that these seizures can be refractory to 
conventional anticonvulsant regimens (27). Repetitive seizures and status 
epilepticus may result. Hemoperfusion, dialysis, and activated charcoal 
all have their advocates for acute therapy, and some experts believe that 
aggressive measures should be initiated if theophylline serum levels reach 
100 µg/ml (35,36,37).Isoniazid is another drug that requires non-
conventional therapeutics.  Due to its action as an antagonist to pyridoxal 
phosphate, treatment includes intravenous pyridoxine (27,28). 
Treatment of other drug-induced seizures generally respond to 
benzodiazepines or barbiturates, and these should be considered first line 
options (29). Phenytoin is not particularly effective against most drug-
induced convulsions, especially those triggered by B-lactam antibiotics. 
Hemodialysis may be taken into consideration if seizures are recurrent, 
particularly if renal failure  complicates drug elimination. 
Treatment Protocol  
Management of IMCU seizures and SE should include emergent 
medical management, termination of seizures, prevention of recurrence of 
seizures, and prevention or treatment of complications. Clinical 
assessment was used to monitor the response to the treatment in almost 
half the cases. 
The specialized protocol for the treatment of seizures in IMCU 
setting is as follows.  
As a general rule, one brief GTCS seizures in the ICU is not an 
indication for AED administration. By the time the drugs are available at 
the bedside, the seizure was usually over. Close monitoring of the 
patients vital signs, bed padding, and the initiation of a workup for 
identifying the cause are usually adequate measures. 
 
 
Table : (A) MANAGEMENT OF BRIEF SINGLE ICU SEIZURE 
(<60S)
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Observe. Eliminate etiology.
 
Consider chronic therapy: PHT (15-20mg/kg) or fosphenytoin (15-
20mg/kg) PHT equivalents (PE) loading dose and 300-400mg/d. Goal 
serum of 10-20 microgram/ml or free level 1-2 microgram/ml. 
PHT intolerant patient: intravenous / oral VPA (15-20 mg/kg load, 
maintenance 600-3000mg/d) or oral CBZ (600-1200 mg/d). 
Seizure precautions: padded bed rails, increased observation. 
 
Table : (B) MANAGEMENT OF A PROLONGED SEIZURE OR 
MORE THAN ONE SEIZURE IN THE ICU
38
 
Check oxygen saturation, vital signs. Consider intubation, if risk of 
aspiration. 
Intravenous BDZ, e.g., lorazepam (1-2mg), DZ (10-20mg), or 
midazolam (2-5mg) with concurrent loading dose of PHT or 
fosphenytoin (PE) of 15-20 mg/kg and maintenance of 300-400 mg/d. 
PHT-intolerant patients: VPA (intravenous load 15-20mg/kg), with 
maintenance at 600mg every 6 hr. 
Seizure precautions: padded bed rails, increased observation. 
 
 
  
Table : (C) MANAGEMENT OF STATUS EPILEPTICUS 
ABC: preserve airway and oxygenation by intubation. 
Measure blood glucose at bedside. Give 100 mg iv thiamine and glucose, 
only if <40-60 mg/100 dL or unable to  have a fast result. At the same time 
draw blood for blood count, electrolytes, liver enzymes, creatinine kinase, 
toxicology screen, arterial blood gases, and AED levels. 
Immediate intravenous BDZS: lorazepam (5-10mg), DZ (20-40mg), or 
midazolam (5-20 mg) over 5 min. 
PHT loading dose of 20 mg/kg at 50 mg/min or fosphenytoin, 20 mg/kg PE 
at 150 mg/min. Consider VPA intravenous load of 15-20 mg/kg, 
maintenance 400-600 mg every 6 h in PHT-intolerant patients. 
Consider EEG, if available 
If seizure continue, PHT or fosphenytoin (additional 5-10 mg/kg or 5-10 
mg/kg PE). Consider VPA intravenous load of 15-20 mg/kg, maintenance 
400-600mg every hr. 
Hemodynamic support consists of fluids, pressors, and inotropes. 
      Add more BDZ if necessary, and consider weaning infusion agent several 
hours later (preferably 12-24 h) while optimal serum anticonvulsant levels 
are documented. 
      If seizures persist, consider prolonged barbiturate or anesthetic coma with 
pentobarbital (12mg/kg at 0.2-0.4mg/kg/min followed by an infusion of 
0.25-2 mg/kg/h) for continued EEG suppression. 
      (Ref-39,40,41,42,43,44,45,46,47,48,38) 
Prophylactic Therapy for Seizures 
Patients in the ICU frequently suffer from a cerebral disturbance 
which carries a risk of seizures. Thus the issue is raised whether the 
benefit of seizure prevention outweighs its potential toxicity. As stated 
earlier, many seizures in the ICU are manifestations of transient 
metabolic or physiological abnormalities and the risk of recurrence is low 
if homeostasis is restored. For patients with structural pathology of the 
CNS, however, the risk of recurrence is frequently high. 
Cerebrovascular accidents are a precipitating cause of seizures in 
3-6% of patients (30, 31). Whether all stroke patients, as a group, should 
receive prophylactic anticonvulsant therapy has not been fully 
established. Hemorrhagic stroke carries a two-fold increase in the risk of 
seizures compared to ischemic infarction. Thus elderly patients, who are 
confused at the beginning and those who do have an early seizure (<1 
week after stroke) have a high risk of recurrence and should therefore be 
considered for prophylactic therapy (31). 
Patients with an intracranial tumor are at high risk for seizures, and 
are frequently prescribed prophylactic seizure medication. It is known for 
certain that these patients with cerebral tumors, particularly gliomas, have 
a high recurrence rate of seizures. Once they occur, prophylactic therapy 
is mandated, although incompletely effective in more than 25% of cases 
(32).  
In case of head injury, as stated previously, the risk of seizures in 
early post-trauma period is approximately 4%. Offered appropriate 
treatment, reports suggest that the occurrence of a seizure does not 
influence the ultimate neurological recovery (33). Prophylaxis against 
seizures has not been demonstrated to prevent the possibility of epilepsy 
following recovery in a prospective cohort. However, the likelihood of 
further seizures and neurological deterioration does support aggressive 
treatment following an initial convulsion (34). 
Summary  
Seizures occurring in the IMCU settings are more difficult to 
prevent, diagnose, and treat effectively than those manifesting outside the 
ICU or hospital. Diagnosis is challenging when only subtle clinical 
evidence is present and the EEG is not conclusive. The use of variety of 
medications and the clinical management in  an ICU all tend to lower 
seizure threshold rather than elevate it . Moreover, treatment of seizures 
in an ICU setting can also be challenging even in the absence of status 
epilepticus
7
 . 
  
AIMS OF THE STUDY 
 
1. To study the cause of seizures in patients admitted to the IMCU 
2. To study the semiology of seizure and the relation of semiology to 
aetiology 
3. To study the relation of seizures to the final outcome 
  
MATERIALS AND METHODS 
The study was done in Intensive medical care unit, Department of 
Medicine, Tirunelveli medical college, Tirunelveli. The study was done 
in association  with the Departments of Neurology, Biochemistry, 
Pathology, Radiology and Microbiology.  
The study was prospective cross sectional study designed to 
analyze the seizures in the patients admitted in IMCU. The sample size 
was 60 and the study period was from October 2009 to November 2010. 
Case Selection: 
1. All patients admitted to IMCU with seizure were taken for study 
2. All patients who developed seizure while in IMCU treatment were 
taken for study 
3. Only patient above the age of 12 were taken for study 
4. Patients with psychogenic and pseudo seizure were excluded from the 
study  
Methodology 
Clinical data was collected from patients and witnesses in a 
systematic manner and added to a database, which included a checklist of 
seizure antecedents and the symptoms associated with seizure. The first 
task was to ascertain if at all, the presenting complaint was a  seizure. In a 
few instances, even when the presenting history was ambiguous, seizure 
recurrences were witnessed for confirmation. The detailed history for all 
patients was obtained and the history regarding semiology of seizure 
was taken. The involvement of the extremities, eye movements, flexion, 
extension, stiffening of the extremities including any focal movements 
were noted. The clinical diagnosis of the seizure type, whether partial or 
generalized was made. Significant past medical history if any was noted. 
Any evidence of post ictal neurological deficits   were sought. The 
following illness were noted  
1. Fever 
2. Intercurrent illness 
3. Head injury 
4. Intoxication 
5. Toxin exposure 
6. CVA 
7. Electrolyte imbalance 
Significant past history regarding the seizure disorder, non 
compliance of the drugs, diabetes, hypertension, tuberculosis, HIV, SLE, 
COPD and bronchial asthma were noted.  
Complete general examination of the patient and central nervous 
system examination was done. Routine blood investigations, urine 
analysis, blood sugar, urea, serum creatinine, sodium, potassium, 
chloride, bicarbonate, calcium, and magnesium levels estimation were 
done in all patients. 
CT scan brain study plain and if needed contrast was done in most 
of the patients except in few patients in whom the general condition was 
so bad that patient could not be shifted for CT scan 
In needed cases, MRI brain, MRA, MRV was also done 
An attempt was made to do EEG in most of the patients with 16 
channel digital EEG at the earliest. 
 
 
 
 
 
 
 
  
OBSERVATION AND RESULTS
60 patients with seizures were studied. The clinical study was 
statistically analyzed and interpreted according 
significance. The difference between various characters of patients  was  
analyzed  by Means and interpreted by students unpaired t’ test. The 
significance of associations between the factors were analyzed and 
interpreted by the test of significance namely Chi’ 
p’ value < 0.05 was taken into the account of the significance. 
Table 1: 
Sex distribution of patients 
Sex
Male 
Female 
Among the total 60 study subjects 
remaining 21(35%) were female .the male to female ratio in this study 
was 1.8:1 
35%
 
to the appropriate tests of 
– square test (ψ
 
 No Percentage (%) 
 39 65% 
 21 35% 
,39(65%) were male and 
65%
Male 
Female 
2
 ). The 
 
 
Table 2 : 
Age related sex distribution. 
Age group 
(years) 
Male Female Total 
No. % No. % No. % 
10-19 3 7.7 3 14.3 6 10 
20-29 7 17.9 9 42.9 16 26.7 
30-39 7 17.9 1 4.8 8 13.3 
40-49 7 17.9 4 19 11 18.3 
50-59 7 17.9 2 9.5 9 15 
60-69 3 7.7 2 9.5 5 8.3 
70-79 2 5.1 0 0 2 3.4 
80-89 3 7.7 0 0 3 5.0 
Total 39 100 21 100 60 100 
Median(Range) 44(13-89) 28(13-65) 39.5(13-89) 
Mean± S.D 43.9±20 33.3±16.2 40.1±19.3 
‘t’ 2.047.d.f.= 58 
Significance P<0.05 
The above table 2 reveals that the ages of the study subject range 
from 13-89 and the median age of the study group was 39.5 years. The 
ages of the male patients range from 13-89 with median age as 44 and the 
ages of the female patients were ranged between 13-65 with the median 
age of 28 years. The mean ages of the males and females were 43.9±20 
years, and 33.3±16.2 years respectively. The mean age difference 
between the males and female patients is statistically significant as P 
value is less than 0.05 indicating that 
younger age with seizure in this study.
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Table 3: 
Patients with new onset seizure Vs known epileptic patient
New onset
Known epileptic
 
Analysis of the above table indicates that 60% of patients in the 
study developed new onset seizure and the remaining 40% are known 
epileptic who had recurrence of seizure 
 
40%
Type No Percentage 
 36 60% 
 24 40% 
 
60%
New onset
Known epileptic
 
 
Table 4: 
Age distribution of known epileptic and new onset seizure disorder 
patients 
Age group Known seizure patients New onset seizure 
No. % No. % 
10-19 4 16.7 2 5.6 
20-29 5 20.8 11 30.6 
30-39 4 16.7 4 11.1 
40-49 4 16.7 7 19.4 
50-59 4 16.7 5 3.9 
60-69 3 12.5 2 5.6 
70-79 0 0 2 5.6 
80-89 0 0 3 8.3 
Total 24 100 36 100 
Mean± S.D 37.3±16.3 42.5±21 
‘t’ 1.034 
Significance P>0.05 
 
Age does not have a bearing on the recurrence of seizure in a 
known epileptic or for new occurrence of seizure in general public 
 
Table 5: 
Aetiology of seizure in known epileptic patients 
Etiology
Drug 
Hemorrhage
Hyperglycemia
 
The drug withdrawal (seen in 20 cases 83.3%) is the most common 
cause for seizure episode in the known epileptic patient. Among the 24 
cases 3(12.5%) cases were due to vascular 
hemorrhage in 2 cases 
recurrence of episode due to 
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 No Percentage 
withdrawal 20 83.3% 
Vascular 
 2 8.3% 
Infarct 1 4.2% 
Metabolic 
 1 4.2% 
Total  24 100% 
causes of which it was 
and infarct in one cases. Only one
hyperglycemia. 
Vascular Metabolic
12.5
4.2
Etiology
 patient had 
 
Series1
Table 6: 
Causes of new onset seizure  
Causes No Percentage 
1.Vascular   
Infarct  8 22.2%         25% 
Hemorrhage +CVT 1 2.7% 
2.Metabolic   
Hyperglycemia 4 11.1% 
Hypoglycemia  2 5.5%           25% 
Hyponatremia 2 5.5% 
Uremia 1 2.7% 
3.Infection    
TBM 3 8.3% 
Encephalitis 2 5.5% 
4.Tumor/SOL 5 13.8% 
5.Hypoxia  4 11.1% 
6.Toxin  3 8.3% 
7.Unidentified  1 2.7% 
TOTAL  36 100% 
 
Etiologies for the total 36 cases of new   onset seizure were
analyzed. Vascular and metabolic causes being the dominant cause for 
new onset seizure, each
vascular etiology. Hyperglycemia is major metabolic abnormality causing 
seizure. Others are hypoglycemia,
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Table 7: 
Type of seizure encountered 
Type of 
seizure
CPGT
CPS
GTCS
Myoclonus
SPGT
SPS
Total
The above table
GTCS type of seizure was seen in maximum no. of study cases. It is seen 
in 38 (63.3%) patients. 
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Frequency % 
 6 10.0 
 3 5.0 
 38 63.3 
 1 1.7 
 6 10.0 
 6 10.0 
 60 100 
-7 evaluates the seizure types in the study group. 
 
 
CPS GTCS Myoclonus SPGT
5
63.3
1.7
10
Type of Seizure
SPS
10
Table 8: 
          Irrespective of the age the study subjects were classified into two 
categories namely <median and median and above age.  
          Pattern of seizure according to the age group. 
Type of 
seizure 
AGE Total 
<Median Median and above  
Fre % Fre % Fre % 
CPGT 3 10.0 3 10.0 6 10.0 
CPS 1 3.3 2 6.7 3 5.0 
GTCS 21 70.0 17 56.7 38 63.3 
Myoclonus 1 3.3 0 0.0 1 1.7 
SPGT 2 6.7 4 13.3 6 10.0 
SPS 2 6.7 4 13.3 6 10.0 
Total 30 100 30 100 60 100 
 
The above table 6, shows that GTCS was seen in maximum no. of 
patients(38i.e. 63.3% ). Among the 38 cases 21(71%) were less than 40 
years and 17(56.7%) cases were above 40 years. But the difference in the 
type of seizure according to the age group variation is not statistically 
significant ( P value 0.686). 
  
Table 9: 
Causes of status epilepticus 
Etiology  No  Type  Percentage  
1.Known epileptic    
Drug withdrawal  6 GTCS 31.6% 
2.New onset seizure     
Metabolic     
 Hyperglycemia  3 EPC 15.8% 
 Hypoglycemia 1 GTCS 5.3% 
Vascular     
 Infarct  1 CPGT 5.3% 
Infection     
 Meningo 
encephalitis 
1 GTCS 5.3% 
Toxin  3 GTCS 15.8% 
Tumor 1 GTCS 5.3% 
Hypoxia  3 GTCS 15.8% 
TOTAL 19   100% 
         
Among the sixty cases, 19 patients(31.67%) had status epilepticus. 
The presence of status epilepticus among the seizure patients according to 
etiology was associated in the above tabl
commonest cause for the status
cases were due to it. H
partialis continua(15.8%)
 
5%
5%
16%
5%
16%
e -9. Drug withdrawal was 
 epilepticus as 6(31.6%) out of 
yperglycemia most commonly present as epilepsy 
 
 
Causes of status epilepticus 
 
32%
16%
5%
Drug withdrawal 
Hyperglycemia 
Hypoglycemia
Infarct 
Meningo encephalitis
Toxin 
Tumor
Hypoxia 
the 
19(100%) 
 
Table 10: 
Etiology of status epilepticus with mortality  
Etiology  No  Discharged  Expired  
1.Known epileptic    
 Drug withdrawal  6 5 1 
2.New onset seizure     
Metabolic     
 Hyperglycemia  3 2 1 
 Hypoglycemia 1 1 0 
Vascular     
 Infarct  1 1 0 
Infection     
 Meningo encephalitis 1 1 0 
Toxin  3 2 1 
Tumor 1 2 0 
Hypoxia  3 2 1 
TOTAL 19 15 4 
Among the 60 study patients 9 patients expired during the study. 
Out of the 9 (15.0%) mortality cases 4(21.1%) had status epilepticus.The 
above table reveals that the outcome of patients with status epilepticus 
depends upon the underlying etiology rather than the status itself. 
Table 11: 
Etiological association of type of seizure  
Etiology Type of seizure  total 
Known epileptic  CPGT CPS GTCS MYOCLO SPGT SPS  
Drug withdrawal 2 2 12 1 2 1 20 
Vascular         
 Hemorrhage  - - 1 - 1 - 2 
 Infarct  - - 1 - - - 1 
Hyperglycemia  - - 1 - - - 1 
New onset seizure        
Vascular         
Infarct  -acute 
          Chronic 
- 
1 
1 - 
1 
- - 
2 
- 
2 
1 
6 
Hemorrhage  1    1  2 
Metabolic         
Hyperglycemia  - - 1 - - 3 4 
Hypoglycemia - - 3 - - - 3 
Hyponatremia - - 1 - - - 1 
Uremia  - - 1 - - - 1 
Infection         
 a.TBM 1 - 2 - - - 3 
b.Meningoencephalitis  - - 3 - - - 3 
Tumor         
a.Primary  - - 1 - - - 1 
b.Secondary  1  2 - - - 3 
Toxins         
 a.Alcohol - - 2 - - - 2 
b.Endosulphan - - 1 - -  1 
Hypoxia         
a.Hanging - - 3 - - - 3 
b.Pneumothorax  - - 1 - - - 1 
Unidentified  - - 1 - - - 1 
TOTAL 6 3 38 1 6 6 60 
 
The above table list out the diagnosis of all the study subjects with 
underlying etiology that provoked seizure. The most common etiology is 
drug withdrawal (20cases). And the next common is vascular etiology (12 
cases). In all the etiological diagnosis, GTCS type of seizure was the most 
common type. 
 
 
  
Table 12: Shows CT abnormalities in the study group
Infarct
Tumor/SOL
Parenchymal 
hemorrhage
Ring enhancing lesion
Granuloma/calcification
Subdural hemorrhage
       Cortical atrophy was found in combinations with various other 
findings. Chronic infarct with gliosis is seen in maximum of number of 
patients. 
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CT findings No (%) 
 13(54%) 
 5(21%) 
 
 
4(17%) 
 2(8%) 
 2(8%) 
 1(4%) 
54
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Infarct
Tumor/SOL
Parenchymal hemorrhage
Ring enhancing lesion
Ganuloma/calcification
Subdural hemorrhage
 
  
  
Table 13:Basisc underlying cause in patients who 
 
                                                           
 
 
 
 
 
 
Mortality is associated with the underlying etiology and not altered 
by occurrence of single episode of seizure.Tumors,end stage renal 
disease,large hemorrhage,large infarct,severe hypoxia ,drug 
complicated infection, 
1
1
1
Endosulfan poisoning
Hanging with hypoxic encephalopathy
CVA –massive infarct
SOL-primary
CAD/ACS/acute ICH
Bronchogenic carcinoma with secondaries
DM /hydronephrosis
Metobolic encephalopathy/refractory seizure
succumbed
 
all have poor prognosis (Table 13). 
1
1
2
1
1
Endosulfan poisoning
Hanging with hypoxic 
encephalopathy
CVA –massive infarct
SOL-primary
CAD/ACS/acute ICH
Bronchogenic carcinoma 
with secondaries
DM /hydronephrosis
Etiology No
 1
 1
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 1
 1
 1
 1
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withdrawal 
 
 
 
 
 
 
 
 
 
 
Table 14: 
Sex wise distribution of mortality 
Sex Died Survived Total Ψ
2
 d.f. Significance 
fre % fre % fre % 
Male 5 55.6 34 66.7 39 65.0 0.415 1 P=0.519 
Female 4 44.4 17 33.3 21 35.0 
Total 9 100 51 100 60 100 
 
 
The above table – 15 reveals the association of mortality with the 
sex of the patients. Among the total 9 mortality cases, 5(55.6%) cases 
were male and the remaining   4(44.4%) cases were females. The sex 
wise distribution of mortality is not statistically Significant (P>0.05). 
  
Table 15: Association of mortality with status and underlying cause  
Cause Status  YES/NO NO 
Endosulfan poisoning YES 1 
Hanging with hypoxic       
encephalopathy 
YES 1 
CVA –massive infarct YES 2 
SOL-primary NO 1 
CAD/ACS/acute ICH NO 1 
Bronchogenic carcinoma with 
secondaries 
NO 1 
DM /hydronephrosis YES 1 
Metabolic 
encephalopathy/refractory 
seizure 
NO 1 
 
Though the cause for status epilepticus varies among the study 
group, mortality depends upon the severity of the underlying disease as 
shown in table 15. 
 
  
  
  
  
DISCUSSION 
             Among the total study subjects(60),the number of males were 
39(65%),and the females were 21(35%)(table-1) Most authors report a 
small-to-moderate preponderance of men in their  studies of first seizures 
in adults (van Donselaar20, 1992; Musicco, 1997;Hopkins18, 1988; King, 
1998). A male to female ratio of 1.8: 1 is observed in this study, a trend 
noted in other studies. 
The age of study population ranges from 13-89 years. The mean 
age of onset of seizures for the males was 43.9±20,for the females was 
33.3±16.2 years. The occurrence of seizures is earlier in females than the 
males since the mean age for the females was statistically lower than the 
mean age for the males (P<0.05)(Table-2) 
On analyzing the past history of seizures,24(40%) cases had past 
history of seizure and the remaining 36(60%) had new onset seizure. The 
mean age for the known seizure patients is 37.3±16.3,and for the new 
onset cases 42.5±21.(Table-4) 
The etiology for the occurrence of seizure varies in the known 
seizure disorder patients, most of them had seizures due to the drug 
withdrawal (83.3%).about 12.5% cases had vascular etiology, 4.2%cases 
had infection as the cause(Table-5) 
The etiology for the recurrence of seizure episode in known 
epileptic varies.The most common cause being noncompliance of drugs. 
In this study two patients had acute parenchymal hemorrhage induced 
seizure. One patient had hyperglycemia induced seizure which presented 
as Epilepsia Partialis Continua.(Table-5) 
The dominant causes for the development of new onset seizure 
were vascular(25%) and metabolic abnormalities(25%) .Hyperglycemia 
is the most frequent metabolic abnormality encountered. Others are 
hypoglycemia, hyponatremia, and uremia.(Table-6) 
Hypoxia induced seizure had occurred in 4 patients. Attempted 
partial hanging with hypoxia resulted in GTCS type of seizure in 3 
patients. 
The seizure type classified in this study as per International League 
Against Epilepsy-revised classification of epileptic seizures revealed 
generalized seizure (including secondary generalization) in 83.3% and 
partial seizure in 16.7 %.(table -7) 
Zhu PG studied new onset seizures in the ages between 20 and 80 
revealed generalized seizures in 64% and partial in 30%. 
Retrospective study of Perez et al in 250 patients with late onset 
seizures revealed 59% generalized and 41% partial in nature.    
The observation made by Bleck TP,smithMC,Piere Louis SJC et al 
revealed that most seizures occurring in the ICU setting manifest as 
generalized tonic clonic convulsions (90%)including secondary 
generalization. 
The observation of seizure type in IMCU in this study is almost 
similar to the study by Bleck et al
(14,15). 
In contrary, a recent study of Prego-Lopez M, Devinsky O 
identified partial seizures as the most common seizure type in adults.
 
Table 16.compares seizure type encountered in this study with 
various studies. 
Seizure type This study Bleck et al Zhu PG 
GTCS 83.3% 90% 64% 
Partial  16.7% 10% 30% 
 
The seizure typing in this study was entirely made with history and 
observation, .It may be considerably difficult to diagnose patients who  
present with complex partial and other non convulsive seizure, especially 
in a critical care setting where sedative medications are often 
administered but such patients are uncommon 
On analyzing the sex wise distribution of seizure pattern, GTCS 
was the most common seizure type in both sexes. 23 (59%) males and 15 
(71.4%) females were with GTCS type of seizure.    
The type of seizure was analyzed according to the age of the 
patient .GTCS type of seizure was the most common type of seizure in 
both less than median age group and population at and above the median 
age.(table-8) 
The incidence of status epilepticus in this study was 31.67%(19 
patients).Drug withdrawal is the most common cause for the status 
epilepticus and accounts for 6 out of 19 cases of status epilepticus. 
Among the status epilepticus patients  generalized convulsive 
status epilepticus is seen in 15(78.9%) of cases and partial status 
epilepticus was seen in 4(21.1%) cases. 
In patients with no previous history of seizure, the common 
abnormality associated with status epilepticus is hyperglycemia. All the 
three patients with hyperglycemia induced seizure presented with 
Epileptia Partialis continua. Hypoglycemia presented as generalized 
convulsive status epilepticus(GCSE).Most other etiologies had GCSE. 
Mortality associated with status was seen in 4 cases, among which 
underlying etiology was irreversible in 3 patients which resulted in death. 
By the appropriate use of status epileptic treatment protocol (Table-
A,B,C), status epilepticus in all patients were in good control. 
Hyperglycemia was treated with standard insulin regimen and cerebral 
edema was relieved with anti edema measures. 
The common CT abnormality was the chronic infarct with gliosis. 
Some showed tumors,parenchymal haemorrhage,ring enhancing lesion 
and calcification (table-12)  
De Lorenzo & his colleagues in the prospective population based 
epidemiological study in Richmond,Virginia found that  partial status 
epilepticus of various types occur in 25% of cases &non convulsive status 
epilepticus in about 4% of status epilepticus. 
 Table -17 Comparison of types of status epilepticus 
Type of STE This study De Lorenzo & colleagues
18
 
GCSE 78.9% 61% 
Partial SE 21.1% 25% 
 
Only six (31.5%) of the 19 cases of status epilepticus had past 
history of seizures,and the remaining 13 (68.5%) cases ha new onset 
seizure with status .Among the total 36 new onset cases ,13 (36.1%) cases 
had status epilepticus. 
In the retrospective study from Mayo clinic,Wijidicks and 
sharbrough reported that only 7.3% of  new onset seizure cases had status 
epilepticus.
15
 . 
This study has a higher incidence of status  epilepticus  in the new 
onset seizure group compared to the above study. 
The largest single identifiable factor for the GCSE is epilepsies 
associated with low levels of  antiepileptic drugs(AEDs);42%in the  
Richmond study had epilepsy and 34% of adults had low AED levels . 
Cerebro vascular diseases and discontinuation of drugs were the 
most prominent causes of status epilepticus  in another study from 
Richmond,Virginia,each accounting for 22% of all in patient series
18 
. 
Out of the nine mortality cases 4(21.6%) cases had status 
epilepticus .the mortality rate in various studies for  GCSE  ranges from 
15-22% in adults 
18,19,20,21
 
The study conducted by S. K. Gupta, Ashok Parihar in GMC, 
Jammu &Kasmir  revealed that the metabolic abnormalities are 
responsible for the up to 30-35% of seizures in critically ill patients
22
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CONCLUSIONS 
1. The incidence and prevalence of seizure in IMCU was slightly higher 
in males than in females 
2. Mean age of onset seizure for males was 43.9±2, and for females was 
33.3±16.2 indicating that more females were admitted at younger age 
with seizure in this study 
3. Drug withdrawal is the commonest cause of recurrence of  seizure  in 
known epileptics  
4. Vascular and metabolic abnormalities are the dominant causes for new 
onset seizure in IMCU with equal frequency 
5. Hyperglycemia was the commonest metabolic abnormality 
encountered which presented  as Epileptia  partialis continua 
6. Most patients had GTCS type of seizure(including secondary 
generalization) ,as seen in 85% of patients 
7. The age of the patient does not influence the type of seizure 
8. Status epilepticus was mainly due to metabolic abnormality in new 
onset seizure patients 
9. Nature of the critical illness determines the outcome, not altered by 
occurrence of single episode of seizure or even status epileptcus 
10. Use of specialized treatment protocol  for treatment of IMCU seizure 
had resulted in good recovery of the study subjects 
 
SUMMARY 
 
Even though the etiology and presentation of seizure in critically ill 
patients vary, the most common reversible causes like metabolic 
abnormalities, infections, toxins should be sought out in all the cases; and 
by the appropriate management of underlying critical illnesses and by the 
use of specialized  treatment protocol for the IMCU seizures, good 
recovery is possible.   
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PROFORMA 
NAME:                                                                  AGE:                      
SEX: 
Occupation:                           IP no.                 Date and time of admission: 
Date and time of onset of seizure:    
Type of seizure: 
GTCS SPS CPS SPGT CPGT Myoclonus Others 
Frequency of seizures- 
Whether known case of seizure- Yes/No 
If yes, H/o discontinuation of drugs – Yes/No 
H/o fever, vomiting, Headache- Yes/No 
H/o fever, altered sensorium- Yes/No 
H/o trauma- Yes/No 
H/o alcohol ingestion- Yes/No 
H/o any hypoxic state- Yes/No 
H/o poisoning/ drug overdose- Yes/No 
If yes what drug- 
H/o suggestive of CVA- Yes/No 
H/o suggestive of SOL- Yes/No 
H/o suggestive of metabolic abnormality- Yes/No 
  
PAST H/o: 
H/o DM/HT/CAD/ BA/COPD/PT/HIV 
Examination: 
Vitals    PR-       BP-       RR-       Temperature- 
GLASGOW COMA SCORE 
Eye 
Opening 
Verbal 
(Nonintubated) 
Verbal (Intubated) Motor 
Activity 
4—
Spontaneous 
5—Oriented and 
talks 
5—Seems able to 
talk 
6—
Verbal 
command 
3—Verbal 
stimuli 
4—Disoriented and 
talks 
3—Questionable 
ability to talk 
5—
Localizes 
to pain 
2—Painful 
stimuli 
3—Inappropriate 
words 
1—Generally 
unresponsive 
4—
Withdra
ws to 
pain 
1—No 
response 
2—
Incomprehensible 
sounds 
  3—
Decortica
te 
  1—No response   2—
Decerebr
ate 
      1—No 
response 
 
 
Fundus-       
Cranial nerves- 
Motor system- 
Sensory system- 
Spine and skull- 
Meningeal signs- 
Other systems- 
CVS- 
RS- 
P/A- 
Investigations: 
1. Urine Alb-    sugar-             depostis-            ketones- 
2. TC   DC   Hb   ESR 
3. Blood sugar   urea       creatinine 
4. Serum Na+     K+      Ca++     
5. LFT       Bn    SGOT    SGPT    SAP   S.protein   S.Albumin    
6. HIV ELISA- 
7. Lumbar puncture 
8. ABG 
9. ECG 
10. Chest Xray 
11. CT scan 
12. MRI 
13. EEG 
14. Others-Outcome  
 
KEY TO THE MASTER CHART 
A     Abnormal   
CPGT    Complex partial with secondary generalization 
CPS     Complex partial seizure  
CT    CT Scan   
D     Discharge   
DW     Drug withdrawal  
E     Expired   
F     Female    
GTCS    Generalised tonic clonic seizures  
Hyp     Hypoxia   
INF     Infection   
M    Male    
MET    Metabolic cause   
MRI     Magnetic Resonance Imaging 
Myoclo    Myoclonus    
N     No    
Nr     Normal    
NS     Neurological signs on admission  
SD    Seizure Disorder    
SOL     Space occupying lesion  
SPGT    Simple partial with secondary generalization 
SPS     Simple partial seizure  
STE/SE    Status Epileticus   
Tox     Toxin    
Tum     Tumor     
UNI     Unidentified   
VAS    Vascular   
Y     Yes    
 
                  
 
 
 
 
 
